Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Communication
Communication
>
Presentations
In the News
Presentations
Presentations
30 Oct 2024
Amplia Capital Raise - Target Market Determination
30 Oct 2024
Capital Raise Presentation
23 Aug 2024
Managing Director AGM Presentation
12 Jul 2024
Bioshares Conference Presentation
12 Jun 2024
Amplia Company Introduction
11 Jun 2024
Presentation and Webinar
10 Apr 2024
AACR Conference Presentation
09 Oct 2023
AACR Ovarian Cancer Conference Presentation
29 Sep 2023
AACR Pancreatic Cancer Conference Presentation
24 Aug 2023
CEO and MD Presentation to Annual General Meeting
23 Feb 2023
ATX - US Conference Presentation
09 Feb 2023
Amplia Therapeutics - Lorne Cancer Conference Presentation
20 Dec 2022
ATX - 2022 Highlights and Outlining our Plans for 2023
14 Sep 2022
AACR Conference Presentation
25 Aug 2022
CEO & Managing Director Presentation to AGM
25 Jul 2022
Presentation at Major Pancreatic Cancer Conference
12 May 2022
Amplia Presentation to 16th Bioshares Biotech Summit
01 Feb 2022
Amplia Investor Presentation - February 2022
16 Dec 2021
Amplia Provides Updated Investor Presentation
08 Nov 2021
Capital Raising Investor Presentation
19 Oct 2021
Amplia Provides Updated Investor Presentation
28 Sep 2021
Proactive Investors Lifesciences Webinar Presentation
15 Sep 2021
Updated Investor Presentation
27 Aug 2021
Annual General Meeting Video August 2021
28 Jul 2021
Shareholder Update Video July 2021
28 Jul 2021
Shareholder Update Slides July 2021
30 Apr 2021
Shareholder Update Slides April 2021
29 Apr 2021
Shareholder Update Video April 2021
18 Sep 2020
CEO Presentation to 2020 Annual General Meeting
02 Jun 2020
Investor Presentation
17 Dec 2019
Shareholder Update - December 2019